Analysts expect Allient Inc. to report Q3 2026 revenue of $158.20 million and earnings per share of $0.74, while the current stock price of $28.42 remains significantly below the average analyst target of $36.00. The primary story for this quarter is the organic growth within the Aerospace & Defense segment and its resulting impact on consolidated operating margins.
Allient has been aggressively repositioning its portfolio toward higher-margin motion control solutions in medical and defense applications. Investors will also look for confirmation that the company's deleveraging strategy remains on track following recent efforts to reduce the debt-to-EBITDA ratio.